Capitalisation of R&D or advertising expenditure
Prudence also demands that expenditure on things like
research and development or advertising for which future benefits cannot
be clearly identified should not be 'capitalised' (treated as an asset
and carried forward to be matched against revenues earned as a result
of the current expenditure) but must be treated as current revenue expenditure.
Only where future benefits can be clearly and unambiguously related
to such expenditure (e.g., R & D is part of an MOD contract) can it
be treated as an asset - providing future benefits.